Risk factor
Negligible price volatility
Profitability factor
Weak growth
About
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Target Price
The average target price of 4521.T is 4549 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell